Browse our anti-BMI1 (BMI1) Antibodies

Full name:
anti-BMI1 Polycomb Ring Finger Oncogene Antibodies (BMI1)
On are 306 BMI1 Polycomb Ring Finger Oncogene (BMI1) Antibodies from 34 different suppliers available. Additionally we are shipping BMI1 Proteins (13) and BMI1 Kits (12) and many more products for this protein. A total of 342 BMI1 products are currently listed.
AW546694, BMI-1, bmi1, FLVI2/BMI1, Pcgf4, psc1, RNF51, wu:fb17g03, wu:fd18f06
list all antibodies Gene Name GeneID UniProt
BMI1 648 P35226
BMI1 12151 P25916
BMI1 307151  

Show all species

Show all synonyms

Most Popular Reactivities for anti-BMI1 (BMI1) Antibodies

Select your species and application

anti-Human BMI1 Antibodies:

anti-Mouse (Murine) BMI1 Antibodies:

anti-Rat (Rattus) BMI1 Antibodies:

All available anti-BMI1 Antibodies

Go to our pre-filtered search.

Top referenced anti-BMI1 Antibodies

  1. Human Polyclonal BMI1 Primary Antibody for EIA, IHC (p) - ABIN357748 : Smith, Chanda, Lingbeek, Ross, Botstein, van Lohuizen, Cleary: Bmi-1 regulation of INK4A-ARF is a downstream requirement for transformation of hematopoietic progenitors by E2a-Pbx1. in Molecular cell 2003 (PubMed)
    Show all 5 references for 357748

  2. Human Monoclonal BMI1 Primary Antibody for IF, WB - ABIN659173 : Ismail, Andrin, McDonald, Hendzel: BMI1-mediated histone ubiquitylation promotes DNA double-strand break repair. in The Journal of cell biology 2010 (PubMed)
    Show all 4 references for 659173

  3. Human Monoclonal BMI1 Primary Antibody for ICC, FACS - ABIN968985 : Edwards, Witherspoon, Wang, Afrasiabi, Pham, Birnbaumer, Lipkin: Epigenetic repression of DNA mismatch repair by inflammation and hypoxia in inflammatory bowel disease-associated colorectal cancer. in Cancer research 2009 (PubMed)
    Show all 2 references for 968985

  4. Human Monoclonal BMI1 Primary Antibody for ChIP, ICC - ABIN4284857 : Courel, Friesenhahn, Lees: E2f6 and Bmi1 cooperate in axial skeletal development. in Developmental dynamics : an official publication of the American Association of Anatomists 2008 (PubMed)

  5. Human Polyclonal BMI1 Primary Antibody for ICC, IF - ABIN152245 : Kang, Qi, Zuo, Wang, Zou, Schwartz, Cheng, Yeh: SUMO-specific protease 2 is essential for suppression of polycomb group protein-mediated gene silencing during embryonic development. in Molecular cell 2010 (PubMed)

  6. Human Monoclonal BMI1 Primary Antibody for FACS, IP - ABIN4900505 : Shen, Chen, Ding, Qi, Cen, Wang, Yao, Chen: BMI1 reprogrammes histone acetylation and enhances c-fos pathway via directly binding to Zmym3 in malignant myeloid progression. in Journal of cellular and molecular medicine 2014 (PubMed)

  7. Human Polyclonal BMI1 Primary Antibody for IF, WB - ABIN318769 : Lessard, Sauvageau: Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells. in Nature 2003 (PubMed)

  8. Human Polyclonal BMI1 Primary Antibody for FACS, IF - ABIN652702 : Chagraoui, Niessen, Lessard, Girard, Coulombe, Sauvageau, Meloche, Sauvageau: E4F1: a novel candidate factor for mediating BMI1 function in primitive hematopoietic cells. in Genes & development 2006 (PubMed)

  9. Cow (Bovine) Polyclonal BMI1 Primary Antibody for WB - ABIN2778334 : Guney, Wu, Sedivy: Reduced c-Myc signaling triggers telomere-independent senescence by regulating Bmi-1 and p16(INK4a). in Proceedings of the National Academy of Sciences of the United States of America 2006 (PubMed)

More Antibodies against BMI1 Interaction Partners

Zebrafish BMI1 Polycomb Ring Finger Oncogene (BMI1) interaction partners

  1. Bmi1 acts immediately downstream of CCAAT enhancer binding protein-alpha (show CEBPA Antibodies) to regulate the survival and self-renewal of hematopoietic stem cells and contribute to the erythropoietic dysplasia.

Human BMI1 Polycomb Ring Finger Oncogene (BMI1) interaction partners

  1. Loss of BMI1 enhanced ribonuclease activity of polynucleotide phosphorylase and reduced mtRNA stability

  2. These findings uncover a previously unrecognized role for MUC1 (show MUC1 Antibodies)-C in driving BMI1 expression and in directly interacting with this stem cell factor (show KITLG Antibodies), linking MUC1 (show MUC1 Antibodies)-C with function of the PRC1 (show PRC1 Antibodies) in epigenetic gene silencing.

  3. Results show that the expression of BMI1 is elevated in human HBV-related hepatocellular carcinoma tissues.

  4. BMI1 is a downstream target of GSK3 (show GSK3b Antibodies) signaling.

  5. According to our data, significant elevation of the expression of miR (show MLXIP Antibodies)-218 and downregulation of BMI1 were observed in clinical breast cancer specimens compared with normal tissues ( p < 0.0001).

  6. MCM4 (show MCM4 Antibodies) and MCM7 (show MCM7 Antibodies) expression is significantly correlated with Ki-67 (show MKI67 Antibodies), Bmi1, and cyclin E (show CCNE1 Antibodies) expression in esophageal adenocarcinoma, squamous cell carcinoma and precancerous lesions.

  7. newly identified miR (show MLXIP Antibodies)-376c/BMI1 pathway provides an insight into cervical cancer progression

  8. Molecular mechanism studies confirmed that Bmi-1 mediated these effects of miR (show MLXIP Antibodies)-495 on MSCs. Taken together, our data demonstrated that miR (show MLXIP Antibodies)-495 induced senescence of MSCs may be involved in the pathogenesis of pre-eclampsia (PE)

  9. miR (show MLXIP Antibodies)-139-5p expression also blocked self-renewal of bladder cancer stem cells by inhibiting Bmi1. In summary, our study supports that miR (show MLXIP Antibodies)-139-5p acts as a tumor suppressor in bladder cancer development and suppresses cancer stem cell property of bladder cancer. Our study also suggests that miR (show MLXIP Antibodies)-139-5p has the potential to be used as a therapeutic molecule for bladder cancer treatment.

  10. our findings establish an important regulatory role of CK2alpha on BMI1 phosphorylation and stability and implicate the CK2alpha/BMI1 axis in ovarian cancer.

Mouse (Murine) BMI1 Polycomb Ring Finger Oncogene (BMI1) interaction partners

  1. The retinal phenotype of Bmi1(-/-) mice was characterized by loss of heterochromatin, activation of tandem repeats, oxidative stress and Rip3 (show MPRIP Antibodies)-associated necroptosis.

  2. Loss of BMI1 enhanced ribonuclease activity of polynucleotide phosphorylase and reduced mtRNA stability

  3. Inducible fate mapping demonstrates that BMI1 is expressed in vivo by multipotent Olfactory epithelium progenitors. expression of BMI1 and other Polycomb (show CBX2 Antibodies) proteins not previously identified in olfactory basal cells are essential for self-renewal.

  4. We conclude that silencing of Bmi1 by miR (show MLXIP Antibodies)-27b relieves repression of the presynaptic transcriptome and supports neurotransmission in cortical networks.

  5. a full complement of Bmi-1 is required for the intestinal proliferative effects of GLP-2 in both the physiological and pathological setting

  6. Our work revealed that MOZ (show MYST3 Antibodies) and BMI1 regulate HSCs in a synergistic manner by acting on distinct processes required to maintain HSCs.

  7. Bmi-1 played a critical role in the protection from acute tubular necrosis by maintaining mobilization of renal stem cells and would be a novel therapeutic target for preventing the progression of ATN

  8. Bmi1 deletion could substitute for Gata4 (show GATA4 Antibodies) during iCM reprogramming. Thus, Bmi1 acts as a critical epigenetic barrier to iCM production. Bypassing this barrier simplifies iCM generation and increases yield, potentially streamlining iCM production for therapeutic purposes.

  9. Cardiac Bmi1 progenitor cells respond to cardiac injury, contributing to the generation of de novo cardiomyocytes in the adult mouse heart.

  10. Bmi1 is a potential driver oncogene (show RAB1A Antibodies) of bladder cancer, and it may become a potential treatment target for human bladder cancer.

BMI1 Antigen Profile

Antigen Summary

Component of a Polycomb group (PcG) multiprotein PRC1- like complex, a complex class required to maintain the transcriptionally repressive state of many genes, including Hox genes, throughout development. PcG PRC1 complex acts via chromatin remodeling and modification of histones\; it mediates monoubiquitination of histone H2A 'Lys-119', rendering chromatin heritably changed in its expressibility. In the PRC1 complex, it is required to stimulate the E3 ubiquitin-protein ligase activity of RNF2/RING2 (By similarity).

Alternative names and synonyms associated with BMI1

  • BMI1 polycomb ring finger oncogene (LOC100230513) antibody
  • BMI1 polycomb ring finger oncogene (LOC100358360) antibody
  • B lymphoma Mo-MLV insertion region 1a (bmi1a) antibody
  • BMI1 polycomb ring finger oncogene (BMI1) antibody
  • Bmi1 polycomb ring finger oncogene (Bmi1) antibody
  • AW546694 antibody
  • BMI-1 antibody
  • bmi1 antibody
  • FLVI2/BMI1 antibody
  • Pcgf4 antibody
  • psc1 antibody
  • RNF51 antibody
  • wu:fb17g03 antibody
  • wu:fd18f06 antibody

Protein level used designations for BMI1

BMI1 polycomb ring finger oncogene , B lymphoma Mo-MLV insertion region 1 homolog , polycomb complex protein BMI-1-A , polycomb group RING finger protein 4-A , polycomb group ring finger 4 , flvi-2/bmi-1 , murine leukemia viral (bmi-1) oncogene homolog , polycomb complex protein BMI-1 , polycomb group RING finger protein 4 , polycomb group protein Bmi1 , ring finger protein 51 , B lymphoma Mo-MLV insertion region 1 , B lymphoma Mo-MLV insertion region

100230513 Taeniopygia guttata
100358360 Oryctolagus cuniculus
321505 Danio rerio
648 Homo sapiens
510666 Bos taurus
12151 Mus musculus
307151 Rattus norvegicus
487097 Canis lupus familiaris
554342 Felis catus
493647 Gallus gallus
100009347 Oryctolagus cuniculus
Selected quality suppliers for anti-BMI1 (BMI1) Antibodies
Did you look for something else?